Pay in 4 interest-free payments of $7.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Initial oral pharmacokinetic studies show that IDO5L is rapidly cleared (t1/2<0
(2009) Mol
84(4):e475-81
Formula: C17H16F3N3O5S
Co-targeting of enzymatic and scaffolding activities within Ras-MAPK signalling complexes is a therapeutic strategy for overcoming Ras-driven cancers
PRMT1-2e - Protein Arginine Methyltransferase 1 (PRMT1) Inhibitor. CAS# 17328-16-4 279 Initial oral pharmacokinetic studies showPRMT1 2e, CAS No. 17328 16 4, is a potent, specific and cell permeable inhibitor of protein arginine methyltransferase 1 (PRMT1) with an IC50 ~1. 5 M. It has no activity against CARM1 and Set7 9 methyltransferases. It inhibits growth of MCF7a breast cancer cells (IC50 ~1. 97 M) and LNCaP prostate cancer cells (IC50 ~4. 49 M). It can attenuate androgen induced gene expression in LNCaP cells. Product information CAS Number: 17328 16 4 Molecular Weight: